Hanna NH - Search Results

1

Relations of perceived injustice to psycho-spiritual outcomes in advanced lung and prostate cancer: Examining the role of acceptance and meaning making.

Secinti E, Wu W, Krueger EF, Hirsh AT, Torke AM, Hanna NH, Adra N, Durm GA, Einhorn L, Pili R, Jalal SI, Mosher CE. Secinti E, et al. Among authors: hanna nh. Psychooncology. 2022 Dec;31(12):2177-2184. doi: 10.1002/pon.6065. Epub 2022 Nov 11. Psychooncology. 2022. PMID: 36336876 Free PMC article.

2

A phase II study of weekly gemcitabine and paclitaxel in patients with previously untreated stage IIIb and IV non-small cell lung cancer.

Bhatia S, Hanna N, Ansari R, Pletcher W, Einhorn L, Ng E, Sandler A. Bhatia S, et al. Lung Cancer. 2002 Oct;38(1):73-7. doi: 10.1016/s0169-5002(02)00145-9. Lung Cancer. 2002. PMID: 12367796 Clinical Trial.

3

Carboplatin plus paclitaxel and sequential radiation followed by consolidation carboplatin and paclitaxel in patients with previously untreated locally advanced NSCLC. A Hoosier Oncology Group (HOG) phase II study.

Bhatia S, Hanna N, Ansari R, Einhorn L, Sandler A. Bhatia S, et al. Lung Cancer. 2002 Oct;38(1):85-9. doi: 10.1016/s0169-5002(02)00146-0. Lung Cancer. 2002. PMID: 12367798 Clinical Trial.

4

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.

Hanna N, Shepherd FA, Fossella FV, Pereira JR, De Marinis F, von Pawel J, Gatzemeier U, Tsao TC, Pless M, Muller T, Lim HL, Desch C, Szondy K, Gervais R, Shaharyar, Manegold C, Paul S, Paoletti P, Einhorn L, Bunn PA Jr. Hanna N, et al. J Clin Oncol. 2004 May 1;22(9):1589-97. doi: 10.1200/JCO.2004.08.163. J Clin Oncol. 2004. PMID: 15117980 Corrected and republished. Clinical Trial.

5

A phase II study of methylphenidate for the treatment of fatigue.

Hanna A, Sledge G, Mayer ML, Hanna N, Einhorn L, Monahan P, Daggy J, Bhatia S. Hanna A, et al. Support Care Cancer. 2006 Mar;14(3):210-5. doi: 10.1007/s00520-005-0857-9. Epub 2005 Aug 12. Support Care Cancer. 2006. PMID: 16096772 Clinical Trial.

6

Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer.

Hanna N, Bunn PA Jr, Langer C, Einhorn L, Guthrie T Jr, Beck T, Ansari R, Ellis P, Byrne M, Morrison M, Hariharan S, Wang B, Sandler A. Hanna N, et al. J Clin Oncol. 2006 May 1;24(13):2038-43. doi: 10.1200/JCO.2005.04.8595. J Clin Oncol. 2006. PMID: 16648503 Clinical Trial.

7

Elderly patients benefit from second-line cytotoxic chemotherapy: a subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancer.

Weiss GJ, Langer C, Rosell R, Hanna N, Shepherd F, Einhorn LH, Nguyen B, Paul S, McAndrews P, Bunn PA Jr, Kelly K. Weiss GJ, et al. J Clin Oncol. 2006 Sep 20;24(27):4405-11. doi: 10.1200/JCO.2006.06.7835. J Clin Oncol. 2006. PMID: 16983108

8

Gefitinib plus celecoxib in chemotherapy-naïve patients with stage IIIB/IV non-small cell lung cancer: a phase II study from the Hoosier Oncology Group.

Agarwala A, Fisher W, Bruetman D, McClean J, Taber D, Titzer M, Juliar B, Yu M, Breen T, Einhorn LH, Hanna N. Agarwala A, et al. J Thorac Oncol. 2008 Apr;3(4):374-9. doi: 10.1097/JTO.0b013e3181693869. J Thorac Oncol. 2008. PMID: 18379355 Free article. Clinical Trial.

9

Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology.

Hanna N, Neubauer M, Yiannoutsos C, McGarry R, Arseneau J, Ansari R, Reynolds C, Govindan R, Melnyk A, Fisher W, Richards D, Bruetman D, Anderson T, Chowhan N, Nattam S, Mantravadi P, Johnson C, Breen T, White A, Einhorn L; Hoosier Oncology Group; US Oncology. Hanna N, et al. J Clin Oncol. 2008 Dec 10;26(35):5755-60. doi: 10.1200/JCO.2008.17.7840. Epub 2008 Nov 10. J Clin Oncol. 2008. PMID: 19001323 Clinical Trial.

10

Pemetrexed in second line and beyond small cell lung cancer: a Hoosier Oncology Group phase II study.

Jalal S, Ansari R, Govindan R, Bhatia S, Bruetman D, Fisher W, Masters G, White A, Stover D, Yu M, Hanna N; Hoosier Oncology Group. Jalal S, et al. J Thorac Oncol. 2009 Jan;4(1):93-6. doi: 10.1097/JTO.0b013e31818de1e6. J Thorac Oncol. 2009. PMID: 19096313 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

155 results

Search Page